Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on listing of Opus Prodox AB (publ)
Mandate

Vinge advises on listing of Opus Prodox AB (publ)

March 27, 2012

Opus is a company which develops, produces and sells products relating to automotive test equipment, vehicle inspection systems and fleet management for the global market.

Opus has retained Vinge as its legal adviser in relation to the listing. The listing process has commenced in order for the company to be included on the main list of NASDAQ OMX Stockholm in 2012.

Vinge’s team includes responsible partner Anders Strid, Anna Björk Larsson (capital markets), Ulf Käll and Anna Hofling (due diligence and tax) and Emma Kero Ljungberg (project manager for legal due diligence).

 

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

 Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

 Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

 Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024